1. |
Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin North Am, 2012, 30(3): 771-794.
|
2. |
Naidech AM. Intracranial hemorrhage. Am J Respir Crit Care Med, 2011, 184(9): 998-1006.
|
3. |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019). 中华神经科杂志, 2019, 52(12): 994-1005.
|
4. |
何菁, 王芳, 熊璐璐, 等. 脑卒中并发静脉血栓栓塞症的发生情况及危险因素分析. 四川大学学报(医学版), 2023, 54(3): 638-641.
|
5. |
张萍. 神经重症患者危重病情的精准量化评估. 武汉: 华中科技大学, 2018.
|
6. |
Liu S, Wang Y, Gao B, et al. A nomogram for predicting venous thromboembolism in critically ill patients with primary intracerebral hemorrhage. World Neurosurg, 2022, 157: e301-e307.
|
7. |
Chu Q, Liao L, Wei W, et al. Venous thromboembolism in ICU patients with intracerebral hemorrhage: risk factors and the prognosis after anticoagulation therapy. Int J Gen Med, 2021, 14: 5397-5404.
|
8. |
杜伟, 周辉, 魏新亭. AHA/ASA《自发性脑出血诊疗指南(2022 版)》解读. 中华神经医学杂志, 2023, 22(3): 217-221.
|
9. |
Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol, 2017, 2(1): 21-29.
|
10. |
van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010, 9(2): 167-176.
|
11. |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南. 中华医学杂志, 2018, 98(14): 1060-1087.
|
12. |
倪莹莹, 王首红, 宋为群, 等. 神经重症康复中国专家共识(下). 中国康复医学杂志, 2018, 33(3): 264-268.
|
13. |
中华医学会重症医学分会. 重症监护病房患者深静脉血栓形成预防指南. 中国危重病急救医学, 2009, 21(9): 514-517.
|
14. |
陈颖. 危重症患者下肢深静脉血栓影响因素分析及风险预测模型构建. 青岛: 青岛大学, 2021.
|
15. |
宫蓓蕾, 许启霞, 庞颖颖, 等. 静脉血栓栓塞症患者临床特征: 10 年 177 例病例分析. 中华危重病急救医学, 2019, 31(4): 453-457.
|
16. |
Malone PC, Agutter PS. The aetiology of deep venous thrombosis. QJM, 2006, 99(9): 581-593.
|
17. |
高亮, 陈宋育. 美国神经重症学会预防神经重症患者静脉血栓栓塞指南的解读. 中华神经创伤外科电子杂志, 2016, 2(5): 261-270.
|
18. |
袁春艳, 彭卫平, 邓娟娟. 脑出血老年患者术后发生静脉血栓栓塞的危险因素. 吉林医学, 2023, 44(7): 1985-1987.
|
19. |
Dong C, Li Y, Ma Z. Venous thromboembolism after spontaneous intracerebral hemorrhage and the status quo of anticoagulation in this population: a retrospective casecontrol study from a tertiary hospital in China. Clin Neurol Neurosurg, 2023, 231: 107839.
|
20. |
Miao L, Shi J, Yu H, et al. Studies on atrial fibrillation and venous thromboembolism in the past 20 years: a bibliometric analysis via CiteSpace and VOSviewer. J Am Heart Assoc, 2023, 12(17): e029810.
|
21. |
Melmed KR, Boehme A, Ironside N, et al. Respiratory and blood stream infections are associated with subsequent venous thromboembolism after primary intracerebral hemorrhage. Neurocrit Care, 2021, 34(1): 85-91.
|
22. |
王荣荣, 周乾宇, 郭园丽, 等. 脑卒中患者静脉血栓栓塞症风险预测模型的构建及验证. 中华疾病控制杂志, 2023, 27(10): 1161-1166.
|
23. |
石琼娅, 周立宇, 张娇, 等. 预测老年自发性脑出血患者深静脉血栓——基于 MIMIC-Ⅳ数据库回顾性分析. 临床神经外科杂志, 2023, 20(3): 327-331.
|
24. |
Koch V, Biener M, Müller-Hennessen M, et al. Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection. Eur Heart J Acute Cardiovasc Care, 2021, 10(5): 559-566.
|
25. |
Wolberg AS, Sang Y. Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arterioscler Thromb Vasc Biol, 2022, 42(8): 931-941.
|
26. |
Ding J, Yue X, Tian X, et al. Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis. Thromb J, 2023, 21(1): 82.
|
27. |
Wang G, Zhao W, Zhao Z, et al. Leukocyte as an independent predictor of lower-extremity deep venous thrombosis in elderly patients with primary intracerebral hemorrhage. Frontiers in Neurol, 2022, 13: 899849.
|
28. |
Spasić I, Ubavić M, Šumarac Z, et al. Influence of lipid metabolism disorders on venous thrombosis risk. J Med Biochem, 2021, 40(3): 245-251.
|
29. |
Ren W, Huang Q, Fan K, et al. Uric acid played a role in the association between gender and deep vein thrombosis in patients with stroke. Nutr Metab Cardiovasc Dis, 2021, 31(9): 2700-2706.
|
30. |
汤厅均, 张翔, 耿保伟, 等. 脑出血术后下肢深静脉血栓形成的临床特点及危险因素. 血管与腔内血管外科杂志, 2023, 9(2): 250-253, 256.
|
31. |
Kelly J, Hunt BJ, Lewis RR, et al. Dehydration and venous thromboembolism after acute stroke. QJM, 2004, 97(5): 293-296.
|
32. |
张红玲, 许佑冬, 刘正东. 急性脑出血患者 ICU 期间下肢深静脉血栓发生的危险因素分析. 中华神经医学杂志, 2020, 19(5): 488-492.
|
33. |
林鸿辉, 田原卿. 脑出血患者在 ICU 期间下肢深静脉血栓形成的影响因素及中西医结合预防策略. 黑龙江医药, 2023, 36(3): 607-610.
|
34. |
Hallan DR, Simion C, Rizk E. Early versus late tracheostomy in spontaneous intracerebral hemorrhage. Cureus, 2022, 14(4): e24059.
|
35. |
郝广志, 董玉书, 张冰莹, 等. 基于 LASSO-logistic 回归构建脑出血术后下肢静脉血栓的风险预测模型. 中华神经外科疾病研究杂志, 2024, 18(4): 1-6.
|
36. |
Benincasa G, Costa D, Infante T, et al. Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: a new challenge for personalized therapy. Thromb Res, 2019, 177: 145-153.
|
37. |
姚漪婷. 静脉血栓栓塞症遗传特征分析. 广州: 广州医科大学, 2023.
|
38. |
周佳, 严静, 李莉. 重症医学科患者深静脉血栓形成预防现状的研究进展. 中华重症医学电子杂志(网络版), 2020, 6(3): 314-317.
|
39. |
Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon, 2005, 51(2/3): 70-78.
|
40. |
周鑫飞, 严静. 静脉血栓栓塞症风险评估模型在重症监护室中的应用. 心脑血管病防治, 2022, 22(6): 66-70.
|
41. |
刘阳. Caprini 风险评估模型对高血压脑出血住院患者静脉血栓栓塞症的预测价值. 慢性病学杂志, 2022, 23(12): 1817-1820.
|
42. |
张亚斌, 马丹, 李蕊, 等. 危重症患者静脉血栓栓塞症风险预测模型的研究进展. 中国护理管理, 2022, 22(7): 1116-1120.
|
43. |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost, 2010, 8(11): 2450-2457.
|
44. |
李巍, 王莉莉. Padua 血栓评估模型对脑卒中患者静脉血栓栓塞症的评估价值. 中国现代神经疾病杂志, 2020, 20(8): 727-732.
|
45. |
余静, 田鹏, 李玲. Padua 血栓评估模型临床使用现状及分析. 护理实践与研究, 2021, 18(23): 3531-3534.
|
46. |
秦霞, 田利, 李惠玲, 等. 内科住院病人发生静脉血栓栓塞症危险因素的 Meta 分析. 现代预防医学, 2018, 45(4): 753-756.
|
47. |
姚文, 王小玲, 巩树梅, 等. 脑出血患者深静脉血栓形成危险因素的系统评价. 中国护理管理, 2019, 19(9): 1322-1329.
|
48. |
Li J, Wang D, Wang W, et al. In-hospital venous thromboembolism is associated with poor outcome in patients with spontaneous intracerebral hemorrhage: a multicenter, prospective study. J Stroke Cerebrovasc Dis, 2020, 29(8): 104958.
|
49. |
Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc, 1997, 72(4): 297-300.
|
50. |
国际血管联盟中国分部护理专业委员会. 住院患者静脉血栓栓塞症预防护理与管理专家共识. 解放军护理杂志, 2021, 38(6): 17-21.
|
51. |
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141(2 Suppl): 7S-47S.
|
52. |
全国肺栓塞和深静脉血栓形成防治能力建设项目专家委员会《医院内静脉血栓栓塞症防治质量评价与管理指南(2022 版)》编写专家组. 医院内静脉血栓栓塞症防治质量评价与管理指南(2022 版). 中华医学杂志, 2022, 102(42): 3338-3348.
|
53. |
陈熙, 赵玲玲, 张晓娟, 等. 住院患者静脉血栓栓塞症风险感知的研究进展. 护理实践与研究, 2024, 21(2): 249-254.
|
54. |
Fernando SM, Qureshi D, Talarico R, et al. Intracerebral hemorrhage incidence, mortality, and association with oral anticoagulation use: a population study. Stroke, 2021, 52(5): 1673-1681.
|
55. |
Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke, 2022, 53(7): e282-e361.
|
56. |
Ianosi B, Gaasch M, Rass V, et al. Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. Eur J Neurol, 2019, 26(2): 333-341.
|
57. |
Pan X, Li J, Xu L, et al. Safety of prophylactic heparin in the prevention of venous thromboembolism after spontaneous intracerebral hemorrhage: a meta-analysis. J Neurol Surg A Cent Eur Neurosurg, 2020, 81(3): 253-260.
|
58. |
蔡奇宴. 颅内出血继发肺血栓栓塞症患者的真实世界研究. 重庆: 重庆医科大学, 2022.
|